Actively Recruiting
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Led by Tanta University · Updated on 2019-11-13
60
Participants Needed
1
Research Sites
526 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Efficacy and Safety of Nitazoxanide in preventing recurrence of Hepatic Encephalopathy.
CONDITIONS
Official Title
Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cirrhotic patient with at least one previous episode of hepatic encephalopathy.
- Adult patients aged from 20 to 65 years old
You will not qualify if you...
- Active gastrointestinal tract bleeding.
- Major psychiatric illness such as psychosis or epilepsy.
- Renal insufficiency with serum creatinine of 2 mg/dl or higher.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
S
sherief abd-elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here